Table 4.
Incidence of adverse events (based on all dogs treated with at least 1 dose of treatment; safety population)
Event | Imepitoin (n = 114) (%) | Placebo (n = 124) (%) |
---|---|---|
All adverse events | 55 (48) | 13 (10) |
Ataxia | 40 (35) | 2 (2) |
Increased appetite | 21 (18) | 1 (1) |
Lethargy | 14 (12) | 2 (2) |
Emesis | 10 (9) | 1 (1) |
Hyperactivity | 7 (6) | 1 (1) |
Somnolence | 4 (3) | … |
Events with >2.5% frequency are shown. Number of animals affected (at least 1 event).